Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026)
Medtronic (MDT) posted Total Non-Current Liabilities of $41.4 billion for Q2 2026, up 2.28% sequentially from $40.5 billion in Q1 2026, and down 0.51% YoY from $41.7 billion in Q2 2025.
Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Medtronic has reported Total Non-Current Liabilities for 13 years, with the latest figure at $41.4 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities fell 0.51% year-over-year to $41.4 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $41.4 billion (down 0.51% YoY) and the FY2026 annual result came in at $41.4 billion, down 0.51% from the prior year.
- Total Non-Current Liabilities climbed to $41.4 billion in Q2 2026 per MDT's latest filing, from $40.5 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $41.7 billion in Q2 2025 and troughed at $36.2 billion in Q2 2022.
- A 5-year average of $39.0 billion and a median of $39.3 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities fell 14.54% in 2022, then advanced 9.06% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $40.8 billion in 2022, then slipped by 10.22% to $36.7 billion in 2023, then gained by 8.53% to $39.8 billion in 2024, then increased by 2.91% to $41.0 billion in 2025, then gained by 1.2% to $41.4 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $41.4 billion, $40.5 billion, and $41.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 41.44 Bn |
| Jan 23, 2026 | 40.52 Bn |
| Oct 24, 2025 | 40.95 Bn |
| Jul 25, 2025 | 41.03 Bn |
| Apr 25, 2025 | 41.66 Bn |
| Jan 24, 2025 | 38.87 Bn |
| Oct 25, 2024 | 39.79 Bn |
| Jul 26, 2024 | 39.67 Bn |
| Apr 26, 2024 | 38.20 Bn |
| Jan 26, 2024 | 37.43 Bn |
| Oct 27, 2023 | 36.66 Bn |
| Jul 28, 2023 | 37.70 Bn |
| Apr 28, 2023 | 36.92 Bn |
| Jan 27, 2023 | 40.21 Bn |
| Oct 28, 2022 | 40.84 Bn |
| Jul 29, 2022 | 36.88 Bn |
| Apr 29, 2022 | 36.17 Bn |
| Jan 28, 2022 | 37.67 Bn |
| Oct 29, 2021 | 39.33 Bn |
| Jul 30, 2021 | 39.84 Bn |